SCLERODERMA, SYSTEMIC
Clinical trials for SCLERODERMA, SYSTEMIC explained in plain language.
Never miss a new study
Get alerted when new SCLERODERMA, SYSTEMIC trials appear
Sign up with your email to follow new studies for SCLERODERMA, SYSTEMIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for scleroderma lung disease: drug trial targets scarring and symptoms
Disease control Recruiting nowThis study tests whether the drug belimumab can improve lung function and reduce skin thickening in adults with systemic sclerosis (scleroderma) that has caused lung scarring. About 300 participants will receive either belimumab or a placebo alongside their usual treatments. The …
Matched conditions: SCLERODERMA, SYSTEMIC
Phase: PHASE2, PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 17, 2026 03:29 UTC
-
New exercise approach aims to ease scleroderma symptoms
Symptom relief Recruiting nowThis study tests a biopsychosocial exercise program called BETY in 48 children and adults with scleroderma. The goal is to see if it improves physical function, skin health, and overall well-being. Participants are randomly assigned to BETY or standard care, and outcomes are meas…
Matched conditions: SCLERODERMA, SYSTEMIC
Phase: NA • Sponsor: Hacettepe University • Aim: Symptom relief
Last updated May 17, 2026 03:30 UTC
-
Could a citrus flavonoid heal scleroderma finger ulcers?
Symptom relief Recruiting nowThis study tests whether diosmin, a plant-based supplement, can safely help heal open sores on the fingers (digital ulcers) in people with scleroderma. About 45 participants will receive either diosmin or a placebo for 8 weeks, and doctors will track ulcer healing, pain, and side…
Matched conditions: SCLERODERMA, SYSTEMIC
Phase: NA • Sponsor: Primus Pharmaceuticals • Aim: Symptom relief
Last updated May 17, 2026 03:23 UTC
-
Scalp scans may reveal hidden organ risks in scleroderma patients
Knowledge-focused Recruiting nowThis study looks at whether a simple, non-invasive scalp exam (trichoscopy) can detect signs of organ damage in people with systemic scleroderma. Researchers will compare scalp images from 200 patients and healthy volunteers to find patterns linked to lung, kidney, or blood vesse…
Matched conditions: SCLERODERMA, SYSTEMIC
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 17, 2026 03:30 UTC
-
Scientists hunt for clues to stop rare, deadly scleroderma
Knowledge-focused Recruiting nowThis study aims to understand what causes systemic sclerosis (SSc), a rare and serious disease that causes hardening of the skin and lungs. Researchers will collect blood, skin, and DNA samples from 150 people with SSc in Sweden to find markers that predict disease activity and t…
Matched conditions: SCLERODERMA, SYSTEMIC
Sponsor: Sahlgrenska University Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 03:19 UTC